title: Surveillance and medical therapy following endovascular treatment of chronic cerebrospinal venous insufficiency.
abstract: The debate regarding the possible link between chronic cerebrospinal venous insufficiency and multiple sclerosis (MS) is continuously becoming more and more contentious due to the current lack of level 1 evidence from randomized trials. Regardless of this continued uncertainty surrounding the safety and efficacy of this therapy, MS patients from Canada, and other jurisdictions, are traveling abroad to receive central venous angioplasty and, unfortunately, some also receive venous stents. They often return home with few instructions regarding follow-up or medical therapy. In response we propose some interim, practical recommendations for post-procedural surveillance and medical therapy, until further information is available.
authors.affiliation: London Health Sciences Centre, London, Ontario, Canada. Tom.Forbes@lhsc.on.ca
authors.forename: Thomas L
authors.initials: TL
authors.lastname: Forbes
authors.forename: Jeremy R
authors.initials: JR
authors.lastname: Harris
authors.forename: Stewart W
authors.initials: SW
authors.lastname: Kribs
mesh_terms: D017130:Angioplasty; D001401:Azygos Vein; D002561:Cerebrovascular Disorders / Q000150:complications / Q000601:surgery*; D002908:Chronic Disease; D003266:Continuity of Patient Care; D057510:Endovascular Procedures / Q000009:adverse effects; D006801:Humans; D007601:Jugular Veins; D057193:Medical Tourism; D009103:Multiple Sclerosis / Q000209:etiology*; D015607:Stents / Q000009:adverse effects; D014689:Venous Insufficiency